Novartis Gene Therapies, Inc. (Fka Avexis, Inc.)

IL · United States · Reporting entity ID 100000486816

Total reported 2019–2025

$11.5M

#453 of 2,960 reporting companies — 0% of all reported industry payments

$1.84M in general payments across 3,852 records, plus $9.67M in research funding across 1,559 records.

How it breaks down

General payments $1,836,735

Research funding $9,666,886

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.